China Biologic Products Holdings, Inc. CBPO
Set alert
— — —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 4.63B
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 20.94
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 19, 2021
- 50-d avg
- 117.97
- 200-d avg
- 117.60
- 1y target
- 102.78
Key statistics
- Market cap
- 4.63B
- Trailing P/E
- 31.41
- Forward P/E
- 20.94
- Price / sales
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- 50-day average
- 117.97
- 200-day average
- 117.60
Analyst view
Consensus: hold
Hold
Price target (mean) 102.78
- Target (low)
- 77.00
- Target (mean)
- 102.78
- Target (high)
- 119.00
Ratings (0m) 9 8 buy · 1 hold · 0 sell
- Strong buy3
- Buy5
- Hold1
- Sell0
- Strong sell0
Next earnings
May 19, 2021
Expected May 19, 2021. Consensus EPS estimate 0.00.
Financials — quick view
CBPO Revenue — quarterly 112.13M
CBPO Net income — quarterly 23.67M
CBPO EPS — quarterly 0.61
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| May 19, 2021 | Mar 1, 2021 | 0.00 | — | — | — |
| Mar 29, 2021 | Dec 1, 2020 | 0.00 | — | — | — |
| Nov 24, 2020 | Sep 1, 2020 | 1.28 | — | — | — |
| Aug 17, 2020 | Jun 1, 2020 | 1.28 | — | — | — |
| May 20, 2020 | Mar 1, 2020 | 1.38 | — | — | — |
| Mar 12, 2020 | Dec 1, 2019 | 0.00 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 11, 2019 | Jefferies | down | Hold | Underperform |
| Nov 5, 2018 | Morgan Stanley | down | Overweight | Equal-Weight |
| May 14, 2018 | Jefferies | down | Buy | Hold |
| Aug 8, 2016 | Jefferies | main | — | Buy |
| Mar 1, 2016 | Credit Suisse | down | Outperform | Neutral |
| Feb 29, 2016 | Jefferies | main | — | Buy |
News
- China Biologic Announces Completion of Going Private Transaction
- China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2020
- Stocks That Hit 52-Week Highs On Friday
- China Biologic Products Holdings, Inc. (CBPO) CEO Joseph Chow on Q3 2020 Results - Earnings Call Transcript
- China Biologic Products to Report Third Quarter 2020 Financial Results
- China Biologic Products Holdings, Inc. (CBPO) CEO Joseph Chow on Q2 2020 Results - Earnings Call Transcript
- The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test
- The Week Ahead In Biotech: Aquestive Awaits FDA Decision, Earnings Flow Slows
- Brokerages Anticipate China Biologic Products Holdings Inc (NASDAQ:CBPO) Will Post Earnings of $1.38 Per Share
- China Biologic Products (NASDAQ:CBPO) Shares Up 0.9%
Your note
Sign in to keep a note on CBPO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| GANG YANG | Officer | Sale | Aug 14, 2016 | 32,242 |
| GAO DAVID XIAOYING | Chief Executive Officer | Sale | Feb 28, 2017 | 395,347 |
| LI DAVID HUI | Director | Stock Award(Grant) | Aug 10, 2016 | 269 |
| LIU WENFANG | Director | Sale | Aug 14, 2016 | 3,383 |
| LIU ZHIJING | Officer | Sale | May 8, 2017 | 4,611 |
| LU YUNGANG | Director | Stock Award(Grant) | Aug 3, 2016 | 18,000 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Hillhouse Capital Advisors Ltd. | 7.53% | 2,962,076 | 349.85M | Dec 30, 2020 |
| Temasek Holdings (Private) Limited | 3.15% | 1,240,000 | 146.46M | Dec 30, 2020 |
| Pentwater Capital Management Lp | 2.99% | 1,178,000 | 139.13M | Dec 30, 2020 |
| Bank of America Corporation | 2.16% | 851,521 | 100.57M | Dec 30, 2020 |
| Capstone Investment Advisors, LLC | 1.95% | 766,288 | 90.51M | Dec 30, 2020 |
| Vanguard Group, Inc. (The) | 1.90% | 747,065 | 88.24M | Dec 30, 2020 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares NASDAQ Biotechnology ETF | 0.82% | 322,380 | 38.17M | Mar 30, 2021 |
| Vanguard International Stock Index-Emerging Markets Stk | 0.78% | 306,774 | 36.15M | Jan 30, 2021 |
| Vanguard International Stock Index-Total Intl Stock Indx | 0.76% | 299,129 | 35.25M | Jan 30, 2021 |
| Vanguard Intl Equity Index Fds-FTSE All World ex U.S. Index Fund | 0.11% | 41,519 | 4.89M | Jan 30, 2021 |
| Fidelity SAI Emerging Markets Low Volatility Index Fund | 0.10% | 38,992 | 4.66M | Feb 27, 2021 |
| Schwab Strategic Tr-Schwab Emerging Markets Equity ETF | 0.07% | 27,643 | 3.29M | Nov 29, 2020 |